세계의 의료 조사 시장 보고서(2025년)
Medical Irradiation Global Market Report 2025
상품코드 : 1825452
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,430,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,294,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,159,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 의료 조사 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년까지 33억 2,000만 달러로 성장해, CAGR은 14.1%로 예상됩니다. 예측기간의 성장은 암 의료를 개선하기 위한 정부의 대처, 조기발견 및 조기치료에 대한 의식의 고조, 가처분소득 증가, 정밀의료에 대한 주목의 고조, 표적암 치료에 대한 수요의 고조에 기인하는 것으로 예측됩니다. 예측기간의 주요 동향으로는 방사선 치료에서의 인공지능 통합, 온라인 적응방사선 치료, 저분할 방사선 치료의 보급, 정밀암 치료를 위한 양자선 치료, 영상 유도 방사선 치료(IGRT)로의 시프트 등을 들 수 있습니다.

향후 5년간의 성장률 14.1%라는 예측은 지난 예측으로부터 0.2% 소폭 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 무역마찰은 스웨덴과 스위스에서 개발된 멸균장치와 치료용 방사선 모듈의 가격을 높여 멸균 공정의 지연과 종양과의 비용 상승을 초래함으로써 미국의 암치료센터에 지장을 초래할 가능성이 있습니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 보입니다.

암의 유병률 증가는 향후 몇 년간의 의료 조사 시장의 성장을 견인할 것으로 예측됩니다. 암은 통제 불가능한 세포 증식을 특징으로 하고, 다양한 장기에 영향을 미치고, 세계적으로 중대한 이환율과 사망률로 이어집니다. 의료 조사는 암치료에 있어서 중요한 역할을 담당하고 있으며, 표적방사선을 이용하여 건강한 조직에 대한 해를 최소화하면서 암세포에 데미지를 주거나 파괴하기도 합니다. 예를 들어 미국에 본사를 둔 비영리 의료 단체인 Leukemia & Lymphoma Society의 보고서에 따르면 2023년에는 미국에서 184,720명이 백혈병, 림프종, 골수종으로 진단될 것으로 예측했습니다. 게다가 미국에서는 2023년에 약 195만 8310명이 새롭게 암으로 진단되어 그 중 백혈병, 림프종, 골수종이 9.4%를 차지할 것으로 예측되고 있습니다. 그 결과, 암의 높은 이환율이 의료 조사 시장의 성장에 박차를 가하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

JHS
영문 목차

영문목차

Medical irradiation refers to the targeted use of radiation in treating diseases, particularly cancer, where controlled doses are applied to damage or destroy specific cells while minimizing their impact on healthy tissues. It is employed in diagnostic settings to produce images of internal structures or functions, facilitating the identification and diagnosis of various medical conditions.

The disease types of medical irradiation include trisomy 21, translocation medical irradiation, and mosaic medical irradiation. Trisomy 21 is a genetic condition characterized by the presence of an extra copy of chromosome 21, leading to Down syndrome. The treatment types are categorized into two categories such as diagnosis and therapy. The distribution channels include direct tenders, retail sales, and others. The end users are hospitals, clinics, homecare settings, therapy centers, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The disease types of medical irradiation include trisomy 21, translocation medical irradiation, and mosaic medical irradiation. Trisomy 21 is a genetic condition characterized by the presence of an extra copy of chromosome 21, leading to Down syndrome. The treatment types are categorized into two categories such as diagnosis and therapy. The distribution channels include direct tenders, retail sales, and others. The end users are hospitals, clinics, homecare settings, therapy centers, and others.

The medical irradiation market size has grown rapidly in recent years. It will grow from $1.69 billion in 2024 to $1.96 billion in 2025 at a compound annual growth rate (CAGR) of 16.4%. The growth in the historic period can be attributed to increasing prevalence of cancer, growing adoption of radiation therapy, rising geriatric population, increasing demand for non-invasive treatment options, and expansion of healthcare infrastructure.

The medical irradiation market size is expected to see rapid growth in the next few years. It will grow to $3.32 billion in 2029 at a compound annual growth rate (CAGR) of 14.1%. The growth in the forecast period can be attributed to government initiatives to improve cancer care, growing awareness about early detection and treatment, rising disposable income, increasing focus on precision medicine, and rising demand for targeted cancer therapies. Major trends in the forecast period include integration of artificial intelligence in radiation therapy, online adaptive radiotherapy, popularity of hypo fractionated radiation therapy, proton therapy for precise cancer treatment, and shift towards image-guided radiation therapy (IGRT).

The forecast of 14.1% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. cancer treatment centers by inflating prices of sterilization equipment and therapeutic radiation modules developed in Sweden and Switzerland, resulting in delayed sterilization processes and higher oncology department costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of cancer is expected to drive the growth of the medical irradiation market in the coming years. Cancer is characterized by uncontrolled cell growth, affecting various organs and leading to significant morbidity and mortality globally. Medical irradiation plays a vital role in cancer treatment, using targeted radiation to damage or destroy cancer cells while minimizing harm to healthy tissues. For example, a report by the Leukemia & Lymphoma Society, a US-based non-profit health organization, predicts that in 2023, 184,720 individuals in the US will be diagnosed with leukemia, lymphoma, or myeloma. Additionally, approximately 1,958,310 new cancer cases are expected to be diagnosed in the US in 2023, with leukemia, lymphoma, and myeloma accounting for 9.4% of those cases. As a result, the high incidence of cancer is fueling the growth of the medical irradiation market.

Major companies operating in the medical irradiation market are developing innovative solutions, such as the Premium Dual-Energy Mobile System, to gain a competitive advantage. A Premium Dual-Energy Mobile System is a high-end medical imaging device that integrates dual-energy technology for enhanced diagnostic capabilities while offering mobility across different clinical settings, providing advanced imaging solutions at the point of care. For instance, in July 2023, KA Imaging, a Canada-based manufacturer, unveiled its Reveal Mobi Pro dual-energy mobile X-ray system. The Reveal Mobi Pro is a comprehensive mobile X-ray solution that combines SpectralDR technology with KA Imaging's Reveal 35C detector. At the bedside, Reveal's capacity to take dual-energy and conventional images simultaneously with a single exposure enhances patient and hospital results while safeguarding income by lowering outflows.

In October 2022, Halma plc, a UK-based technology company, acquired IZI medical products for £138 million ($146 million). Through the acquisition, Halma aims to diversify its portfolio of physician-led innovations, enhancing its ability to meet patient demands and deliver high-quality healthcare services. IZI Medical Products is a US-based manufacturer of radiation therapy, diagnostic radiology, and image-guided surgery medical devices.

Major companies operating in the medical irradiation market are Hitachi Ltd., Thermo Fisher Scientific Inc., Toshiba Corporation, Siemens Healthcare GmbH, Koninklijke Philips N.V., GE Healthcare Company, Mayo Clinic Health System, Canon Medical Systems R&D (Dalian) Co. Ltd., PerkinElmer Inc., Varian Medical Systems Inc., Elekta AB, Accuray Incorporated, Ion Beam Applications S.A., Brainlab AG, ViewRay Technologies Inc., Mevion Medical Systems Inc., RaySearch Laboratories AB, NTP Radioisotopes SOC Ltd., RefleXion Medical Inc., Vision RT Ltd., Sun Nuclear Corporation, IZI Medical Products LLC, Eckert & Ziegler BEBIG GmbH, C-RAD AB, Panacea Medical Technologies Pvt. Ltd., Standard Imaging Inc., CIVCO Radiotherapy Inc., IntraOp Medical Corporation, RTsafe Solutions Ltd., ASG Superconductors S.p.A., Mirada Medical Corporation

North America was the largest region in the medical irradiation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical irradiation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the medical irradiation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The medical irradiation market includes revenues earned by entities by providing services such as diagnostic imaging services, radiation therapy, radiopharmaceutical and radiation safety, and dosimetry services. The market value includes the value of related goods sold by the service provider or included within the service offering. The medical irradiation market consists of sales of products such as radiation therapy equipment, diagnostic imaging devices, radiopharmaceuticals, and nuclear medicine devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Medical Irradiation Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on medical irradiation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for medical irradiation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The medical irradiation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Medical Irradiation Market Characteristics

3. Medical Irradiation Market Trends And Strategies

4. Medical Irradiation Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Medical Irradiation Growth Analysis And Strategic Analysis Framework

6. Medical Irradiation Market Segmentation

7. Medical Irradiation Market Regional And Country Analysis

8. Asia-Pacific Medical Irradiation Market

9. China Medical Irradiation Market

10. India Medical Irradiation Market

11. Japan Medical Irradiation Market

12. Australia Medical Irradiation Market

13. Indonesia Medical Irradiation Market

14. South Korea Medical Irradiation Market

15. Western Europe Medical Irradiation Market

16. UK Medical Irradiation Market

17. Germany Medical Irradiation Market

18. France Medical Irradiation Market

19. Italy Medical Irradiation Market

20. Spain Medical Irradiation Market

21. Eastern Europe Medical Irradiation Market

22. Russia Medical Irradiation Market

23. North America Medical Irradiation Market

24. USA Medical Irradiation Market

25. Canada Medical Irradiation Market

26. South America Medical Irradiation Market

27. Brazil Medical Irradiation Market

28. Middle East Medical Irradiation Market

29. Africa Medical Irradiation Market

30. Medical Irradiation Market Competitive Landscape And Company Profiles

31. Medical Irradiation Market Other Major And Innovative Companies

32. Global Medical Irradiation Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Medical Irradiation Market

34. Recent Developments In The Medical Irradiation Market

35. Medical Irradiation Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기